CRDLCardiol Therapeutics Inc.
1.690CAD0.00%Mkt Cap: 194.81M CADP/E: Last update: 2026-06-01

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx,…

Indicators:|

Key Statistics

Company
Market Cap194.81M CAD
Enterprise Value156.63M CAD
Revenue (TTM)
Gross Profit
Net Income (TTM)-33.82M CAD
Revenue/Share
Last Price1.690 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees18
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-6.04
PEG
EV/EBITDA-4.41
EV/Revenue
P/S
P/B7.61
EPS (TTM)-0.39
EPS (Forward)-0.28
52W Range
1.22542% of range2.330
52W High2.330 CAD
52W Low1.225 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-189.17%
ROA-143.18%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-23.85M CAD
CapEx (TTM)24.48K CAD
FCF Margin
FCF Yield-7.06%
Net Debt-27.56M CAD
Net Debt/EBITDA0.78
Balance Sheet
Debt/Equity0.01
Current Ratio4.39
Quick Ratio3.93
Book Value/Sh0.2220 CAD
Cash/Share0.2540 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)6.000 CAD
Target Range5.000 CAD7.000 CAD
# Analysts2
Ownership
Shares Out.115.27M
Float94.00M
Insiders2.38%
Institutions24.92%
Short Interest
Short Ratio1.8d
Short % Float0.18%
Short % Out.0.18%
Shares Short204.95K
Short (prev mo.)79.36K
Technical
SMA 501.811 (-6.7%)
SMA 2001.546 (+9.3%)
Beta
S&P 52W Chg27.70%
Avg Vol (30d)89.70K
Avg Vol (10d)43.76K
Technical Indicators
RSI (14)39.6
MACD-0.0156
MACD Signal-0.0023
MACD Hist.-0.0133
BB Upper1.893 CAD
BB Middle1.808 CAD
BB Lower1.724 CAD
BB Width9.36%
ATR (14)0.0909 CAD
Vol Ratio (20d)0.84x